General Information
Version
6.7
Revision date
2023-02-24
Product name
Rivastigmine Tartrate, United States Pharmacopeia (USP) Reference Standard
CAS No.
129101-54-8
REACH No
A
Emergency telephone
+56 2 2581 4934
Icons in SDS
Company Information
company name
Merck S.A
e-mail address of the competent person responsible for the Safety Data Sheet
atencionclientes@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300, H411
Hazard statements
Code
Statements
H300
Fatal if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H300 Fatal if swallowed. H411 Toxic to aquatic life with long lasting effects. H300 Fatal if swallowed.
Precautionary statements
P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P391 Collect spillage. P405 Store locked up. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P405 Store locked up.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 2), H300 Long-term (chronic) aquatic hazard (Category 2), H411 For the full text of the H-Statements mentioned in this Section, see Section 16.
